Ikena Oncology (IKNA) announced the appointment of Kristin Yarema, Ph.D. as Chief Executive Officer of ImageneBio, of the combined company after the anticipated closing. Dr. Yarema joins the team after most recently serving as President and Chief Executive Officer and as a member of the Board of Directors of Poseida Therapeutics (PSTX)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IKNA: